# Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes

> **NCT06671340** · NA · NOT_YET_RECRUITING · sponsor: **Elaine Chow** · enrollment: 30 (estimated)

## Conditions studied

- Diabetes Mellitus
- Prediabetes / Type 2 Diabetes

## Interventions

- **DRUG:** Dorzagliatin

## Key facts

- **NCT ID:** NCT06671340
- **Lead sponsor:** Elaine Chow
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-04-02
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-01-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671340

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671340, "Chronic Dorzagliatin on Insulin and Incretin Function in Intermediate Hyperglycemia and Type 2 Diabetes". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06671340. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*